Publications
- 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity2012 | First Faculty of Medicine
- Blast phase of chronic myeloid leukaemia2023 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Symposium and workshop - actual challenges and implementation of new technologies in the treatment of chronic myeloid leukaemia2023 | First Faculty of Medicine
- Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining2021 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells2021 | First Faculty of Medicine
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.2018 | First Faculty of Medicine, Central Library of Charles University
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia2018 | First Faculty of Medicine, Central Library of Charles University
- Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment2017 | First Faculty of Medicine, Faculty of Science, Faculty of Medicine in Hradec Králové
- GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia2016 | First Faculty of Medicine
- Epigenetic Control of SPI1 Gene by CTCF and ISWI ATPase SMARCA52014 | First Faculty of Medicine
Loading network view...